STOCK TITAN

UBS ETRACS Alerian MLP Index ETN Series B SEC Filings

AMUB NYSE

Welcome to our dedicated page for UBS ETRACS Alerian MLP Index ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.

UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.

For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.

Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Intel Corporation, maturing on or about January 21, 2027. Each Note has a principal amount of $10, with a minimum investment of 100 Notes (a $1,000 investment).

Investors receive a contingent coupon on each coupon payment date only if Intel’s closing share price on the related observation date is at or above a preset coupon barrier. The Notes are automatically called early if Intel’s share price on any observation date before maturity is at or above the initial level, in which case investors receive principal plus the due coupon, and the product terminates.

If the Notes are not called and Intel’s final share price is at or above a specified downside threshold, investors receive full principal at maturity (plus any final coupon if the barrier is met). If the final price is below the downside threshold, repayment is reduced in line with the stock’s negative performance, and investors can lose some or all of their initial investment. All payments depend on the creditworthiness of UBS. The estimated initial value per Note on the trade date is expected to be between $9.45 and $9.70.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $480,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Micron Technology, Inc., maturing on January 21, 2028. Each Note has a principal amount of $10 and the minimum investment is 100 Notes, or $1,000.

The Notes pay a contingent coupon on scheduled coupon payment dates only if Micron’s closing share price on the related observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period. The Notes are automatically called early if Micron’s share price on any observation date before maturity is at or above the initial level, in which case investors receive the $10 principal per Note plus any due coupon, and the Notes terminate.

If the Notes are not called and, on the final valuation date, Micron’s share price is at or above a specified downside threshold, investors receive the full $10 principal per Note. If it is below that threshold, repayment is reduced in line with Micron’s decline, and investors can lose most or all of their investment. The estimated initial value is $9.79 per Note, and all payments depend on the creditworthiness of UBS AG.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $525,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Vertiv Holdings Co, maturing on January 21, 2028. These unsecured debt notes can pay periodic contingent coupons only when Vertiv’s share price on an observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period.

The notes may be automatically called early if Vertiv’s stock closes at or above the initial level on any observation date before maturity, in which case investors receive the principal plus any due coupon and the product terminates. If the notes are not called and Vertiv’s final level is at or above the downside threshold, investors receive full principal at maturity; if it is below the threshold, repayment is reduced in line with the stock’s decline, and the entire principal can be lost.

The minimum investment is 100 notes at $10 each, and the estimated initial value is $9.75 per note, reflecting UBS’s internal pricing. An example in the document illustrates a contingent coupon rate of 27.59% per annum with a downside threshold and coupon barrier at 70% of the initial level. All payments depend on UBS’s creditworthiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Micron Technology, Inc., maturing on or about January 21, 2028. Each Note has a principal amount of $10, with a minimum investment of 100 Notes (a $1,000 investment).

These Notes can pay periodic contingent coupons only if, on an observation date, the Micron stock price is at or above a specified coupon barrier. The Notes may be automatically called early if Micron’s stock closes at or above the initial level on any observation date before maturity, in which case holders receive the principal plus any due coupon and no further payments.

If the Notes are not called and Micron’s stock is at or above the downside threshold at final valuation, holders receive the full principal (and a final coupon if the coupon barrier is met). If the final level is below the downside threshold, repayment is reduced in line with the stock’s decline, and the entire investment can be lost. All payments depend on the creditworthiness of UBS, and the estimated initial value per Note is expected to be between $9.41 and $9.66.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Vertiv Holdings Co, with a scheduled maturity around January 21, 2028. These are unsecured, unsubordinated debt obligations of UBS and are not bank deposits or FDIC insured.

Investors receive a contingent coupon only on observation dates when Vertiv’s closing level is at or above a coupon barrier; no coupon is paid if the level is below that barrier. The notes are automatically called early if Vertiv’s closing level on any observation date before the final valuation date is at or above the initial level, in which case UBS repays the principal plus any due coupon and makes no further payments.

If the notes are not called and the final Vertiv level is at or above a downside threshold, UBS repays the $10 principal per note at maturity; if it is below that threshold, repayment is reduced in line with Vertiv’s decline and investors can lose all of their investment. The preliminary supplement shows a hypothetical contingent coupon rate of 25.38% per year and a minimum purchase of 100 notes at $10 each, and estimates the initial value per note between $9.38 and $9.63.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Callable Contingent Yield Notes linked to the least performing of the Nasdaq-100 Technology Sector Index, the Russell 2000 Index and the S&P 500 Index, maturing around January 26, 2029. The notes pay a 9.45% per annum contingent coupon (about $7.875 per $1,000 monthly) only when all three indices close at or above 70% of their initial levels on an observation date; otherwise no coupon is paid.

UBS can call the notes in whole, beginning after six months, paying back principal plus any due coupon, with no further payments. If the notes are not called and, at maturity, all indices are at or above 60% of their initial levels, investors receive full principal; if any index is below 60%, repayment is reduced in line with the worst index’s percentage decline, up to a total loss of principal. The notes are unsecured obligations of UBS, not listed on an exchange, and carry issuer credit risk. The estimated initial value is between $954.40 and $984.40 per $1,000 note, reflecting fees, hedging and UBS’ internal funding rate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $1,950,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Amgen Inc., maturing on January 22, 2029. The Notes pay a contingent coupon only on dates when Amgen’s share price is at or above a preset coupon barrier; if it is below, no coupon is paid for that period. On quarterly observation dates before maturity, the Notes are automatically called if Amgen’s share price is at or above the initial level, in which case investors receive the $10 principal per Note plus any due coupon and the product ends early. If the Notes are not called and Amgen’s final share price is at or above the downside threshold, investors receive full principal back; if it is below, repayment is reduced in line with Amgen’s percentage decline and can fall to zero. All payments depend on UBS’s credit, the Notes are not listed on any exchange, the minimum investment is 100 Notes ($1,000), and the estimated initial value is $9.64 per $10 Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Amgen Inc., maturing on or about January 22, 2029. These unsecured debt notes pay a contingent coupon only on dates when Amgen’s closing share price is at or above a preset coupon barrier; if the stock closes below that level on an observation date, no coupon is paid for that period.

The notes can be called early each quarter, beginning about six months after issuance, if Amgen’s share price is at or above the initial level. In that case, investors receive the principal plus any due coupon and the product terminates. If the notes are not called and, on the final valuation date, Amgen’s share price is at or above the downside threshold, investors receive full principal back at maturity. If it is below the downside threshold, repayment is reduced in line with the stock’s decline and investors can lose all of their initial investment.

The minimum investment is 100 notes at $10 each. Any payment, including return of principal, depends on the creditworthiness of UBS, and the estimated initial value per note is expected to be between $9.34 and $9.59. The notes will not be listed on any exchange, and secondary market liquidity may be limited.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $2,299,000 of Trigger Callable Contingent Yield Notes linked to the least performing of the Russell 2000 Index and the S&P 500 Index. The notes pay an 8.80% per annum contingent coupon (paid quarterly as $22 per $1,000) only if, on each observation date, both indices close at or above their coupon barriers set at 70% of initial levels. UBS may, at its discretion, call the notes on any quarterly observation date (other than the final one) and repay principal plus any due coupon.

If the notes are not called and on the final valuation date either index finishes below its downside threshold at 60% of its initial level, investors receive reduced principal based on the negative return of the worst-performing index and can lose all of their investment. The notes are unsecured obligations of UBS, are not listed on any exchange, carry liquidity and reinvestment risks, and have an estimated initial value of $971.60 per $1,000, below the issue price due to fees, hedging costs and UBS’s internal funding rate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $5,670,000 of Trigger Callable Contingent Yield Notes due January 19, 2029, linked to the least performing of the Nasdaq-100® Technology Sector Index, the Industrial Select Sector SPDR Fund and the Utilities Select Sector SPDR Fund. The notes pay an 11.55% per annum contingent coupon (monthly $9.625 per $1,000) only when all three underlyings close at or above 70% of their initial levels on an observation date.

UBS may call the notes in whole on any monthly observation date beginning after six months, paying principal plus any due coupon, with no further payments. If the notes are not called and any underlying finishes below its 70% downside threshold at maturity, investors lose principal in line with the worst performer, up to a total loss. The notes are unsecured obligations of UBS, and the estimated initial value is $986.80 per $1,000 issue price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many UBS ETRACS Alerian MLP Index ETN Series B (AMUB) SEC filings are available on StockTitan?

StockTitan tracks 4496 SEC filings for UBS ETRACS Alerian MLP Index ETN Series B (AMUB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UBS ETRACS Alerian MLP Index ETN Series B (AMUB)?

The most recent SEC filing for UBS ETRACS Alerian MLP Index ETN Series B (AMUB) was filed on January 16, 2026.